Can breast cancer cause malignant pleural effusion?

The pleura are thin layers of tissue surrounding each lung. A small amount of fluid normally helps these layers move smoothly during breathing. Breast cancer may spread to the pleura, where cancer cells can irritate the tissue or interfere with normal fluid drainage. The resulting build-up is called a malignant pleural effusion.

Fluid around the lung can cause breathlessness, a cough, chest heaviness or discomfort, and difficulty lying flat. These symptoms can also have other causes, so they do not by themselves show that an effusion is malignant. A clinician may use an examination and chest imaging, and may remove a sample of fluid for laboratory assessment. The wider cancer history and imaging findings help guide interpretation.

Contact the oncology team promptly if new or worsening breathing symptoms develop. They may arrange imaging to check for fluid and assess its effect on the lung. If fluid is causing significant symptoms, a procedure can drain it and ease pressure; the team may discuss additional approaches if it returns. Treatment is selected according to the breast cancer type, its spread, previous treatment, general health, and your preferences.

Keep a note of when breathlessness started, what activities bring it on, whether it changes when you lie down, and any chest pain or fever. Bring your current medicines and cancer treatment details to the appointment. Do not wait for a routine visit if symptoms are rapidly changing.

Seek urgent medical help for severe or rapidly worsening breathlessness, blue or grey lips, confusion, fainting, or chest pain that is sudden, severe, or associated with sweating. Call emergency services if you cannot speak comfortably because of breathlessness. While waiting, sit upright and follow any breathing or oxygen instructions already provided by your care team.

Ask what the imaging shows, whether a fluid sample is needed, and which other conditions could explain your symptoms. You can also ask how drainage is performed, what improvement to expect, how recurrence would be managed, and whether your current cancer treatment needs review.